{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"11"}],"units":"Participants"}],"description":"The number of patients who experience death that is considered to be primarily attributable to complications of treatment.","groups":[{"description":"Infants (\\<36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.","id":"OG000","title":"Stratum I"},{"description":"Older children (greater than 36 months of age) with tumor histology and immunohistochemical analysis diagnostic of AT/RT.","id":"OG001","title":"Stratum III"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"One patient was ineligible in stratum I and one patient was ineligible in stratum III. There were no patients enrolled in Stratum 2 or 4.","reportingStatus":"POSTED","timeFrame":"During and after completion of study treatment up to 1 year after enrollment.","title":"Toxic Death","type":"PRIMARY","unitOfMeasure":"Participants"}